Browse By Publication: Endocrine Related Cancer
|Up a level|
Number of items: 6.
Brunner, N., Johnson, M.D., Holst-Hansen, C., Kiilgaard, J.F., Thompson, E.W., & Clarke, R. (1995) Acquisition of estrogen independence and antiestrogen resistance in breast cancer : association with the invasive and metastatic phenotype. Endocrine Related Cancer, 2(1), pp. 27-35.
Jeet, Varinder, Tevz, Gregor, Lehman, Melanie, Hollier, Brett, & Nelson, Colleen (2014) Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells. Endocrine Related Cancer, 21(5), pp. 723-737.
Lubik, Amy, Gunter, Jennifer, Hollier, Brett G., Fazli, Ladan, Ettinger, Susan, Stylianou, Nataly, et al. (2013) IGF2 increases de novo steroidogenesis in prostate cancer cells. Endocrine Related Cancer, 20(2), pp. 173-186.
Moore, Nicole L., Buchanan, Grant, Harris, Jonathan M., Selth, Luke A., Bianco-Miotto, Tina, Hanson, Adrienne R., et al. (2012) An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity. Endocrine Related Cancer, 19(4), pp. 599-613.
Stegeman, Shane, Moya, Leire, Selth, Luke A., Spurdle, Amanda B., Clements, Judith, & Batra, Jyotsna (2015) A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer. Endocrine Related Cancer, 22(2), pp. 265-276.
Veveris-Lowe, T.L., Lawrence, M.G., Collard, R.L., Bui, L., Herington, A.C., Nicol, D.L., et al. (2005) Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Endocrine Related Cancer, 12(3), pp. 631-643.